Evidence map›Paper›PMID 39222138›Full record

ArticleIntensive care medicine2024

Comparison of environmental, economic and professional impacts of levetiracetam according to its administration route in intensive care unit.

Solen Santander, Loic Le Guennec, Inès de Maisoncelle, Amélie Liou, Clémence Marois

Abstract readLetterComparative Study
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Choosing Wisely Canada climate-conscious recommendations for critical care medicine.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2026
    Article
  3. Environmental sustainability evidence in critical care medicine: a scoping review.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Solen Santander *Service de Médecine Intensive et Réanimation a Orientation Neurologique, Sorbonne Université, AP-HP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France.
Loic Le Guennec *Service de Médecine Intensive et Réanimation a Orientation Neurologique, Sorbonne Université, AP-HP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France.
Inès de MaisoncelleDirection de la Stratégie et de la Transformation, AP-HP, Paris, France.
Amélie LiouService de Pharmacie, Sorbonne Université, AP-HP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France.
Clémence MaroisService de Médecine Intensive et Réanimation a Orientation Neurologique, Sorbonne Université, AP-HP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière, Paris, France. clemence.marois@aphp.fr.ORCID 0000-0002-3266-0623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnticonvulsantsIntensive Care UnitsLevetiracetamDrug Administration RoutesHumansPiracetamAnticonvulsantsLevetiracetamPiracetam

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.